Clinical Trials Directory

Trials / Completed

CompletedNCT02045173

Automate Detection of Sleep Apnea by ApneascanTM

Screening for Sleep-disordered Breathing in Routine Cardiology Practice: Validation of the Apnea + Hypopnea Detection by an Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy-defibrillator (CRT-D) With Impedance-based Respiration Sensor (ApneaScanTM)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
41 (actual)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to compare, three months after implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy-defibrillator (CRT-D), the apnea-hypopnea index (AHI) obtained from conventional in-lab NPSG/NPG (AHIPSG) with similar indices obtained from autoscoring algorithms of the ApneaScan™, an implantable impedance-based respiration sensor (AHIAS).

Detailed description

This is a prospective, multi center, phase-IV with blinded analysis and central reading of polysomnography trial. The study is performed in patients with a standard CRT-D or Implantable Cardioverter Defibrillator (ICD) devices indication. A total of 160 subjects will be recruited in France. The study duration is 03 months for each subject.

Conditions

Interventions

TypeNameDescription
OTHERApneascan TMAutoscoring algorithms with automatical detection of sleep apnea by the Apneascan TM
DEVICEPolysomnography/polygraphy1 night polysomnography/polygraphy

Timeline

Start date
2014-01-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2014-01-24
Last updated
2016-10-21

Locations

5 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02045173. Inclusion in this directory is not an endorsement.